rs113373353 - RASSF3

Magnitude 2.2 · 1 study on file

Reported associations

  • Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps - Unknown journal (n.d.) · Unknown authors · PubMed 27668658

    ABSTRACT: Large-scale whole genome sequence datasets offer novel opportunities to identify genetic variation underlying human traits. Here we apply genotype imputation based on whole genome sequence data from the UK10K and the 1000 Genomes Projects into 35,981 study participants of European ancestry, followed by association analysis with twenty quantitative cardiometabolic and hematologic traits. We describe 17 novel associations, including six rare (minor allele frequency [MAF]<1%) or low frequency variants (1%<MAF<5%) with platelet count (PLT), red cell indices (MCH, MCV) and high-density lipoprotein (HDL) cholesterol. Applying fine-mapping analysis to 233 known and novel loci associated with the twenty traits, we resolve associations of 59 loci to credible sets of 20 or less variants, a


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • genetic predisposition to cardiometabolic traits Moderate

    Carrier of rs113373353 variant with strong association to cardiometabolic and hematological traits

Screening

  • blood pressure and lipid profile Moderate

    Variant associates strongly with cardiometabolic traits; RASSF3 expression reduced in heart tissue

    routine monitoring per clinical guidelines

  • fasting glucose and metabolic markers Moderate

    Variant associates with cardiometabolic traits; RASSF3 expression reduced in liver

    annual testing or per clinical guidelines